Spruce Biosciences (SPRB) Institutional Ownership → Why Is Gold On a MASSIVE rally? (From Huge Alerts) (Ad) Free SPRB Stock Alerts $0.75 -0.02 (-2.60%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Spruce Biosciences (NASDAQ:SPRB)CurrentInstitutional OwnershipPercentage91.71%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$4.46MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$3.48M Get SPRB Insider Trade Alerts Want to know when executives and insiders are buying or selling Spruce Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SPRB Institutional Buying and Selling by Quarter Ad The Freeport SocietyBill Clinton Backing Biden Replacement???Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast. Spruce Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2024AWM Investment Company Inc.200,000$157K0.0%N/A0.486% 5/10/2024 Acadian Asset Management LLC368,831$289K0.0%N/A0.896% 4/25/2024 Rosalind Advisors Inc.1,508,419$1.19M1.1%-4.9%3.666% 2/14/2024 Superstring Capital Management LP118,814$348K0.2%N/A0.292% 2/13/2024 Armistice Capital LLC2,230,000$6.53M0.1%-27.0%5.478% 2/12/2024 AIGH Capital Management LLC2,123,863$6.22M2.5%+75.4%5.217% Get the Latest News and Ratings for SPRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Spruce Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/9/2024 Worth Venture Partners LLC526,933$1.54M0.8%+74.4%1.294% 11/15/2023 Worth Venture Partners LLC302,074$683K0.4%+8.8%0.742% 11/15/2023 Armistice Capital LLC3,056,000$6.91M0.1%-12.6%7.507% 11/13/2023 AIGH Capital Management LLC1,211,000$2.74M1.3%+9.0%2.975% 7/26/2023 Privium Fund Management B.V.24,554$52K0.0%N/A0.062% 5/15/2023 AIGH Capital Management LLC1,104,000$2.37M0.9%N/A2.778% 5/5/2023 Carlyle Group Inc.2,896,518$6.40M0.2%N/A7.287% 5/3/2023 Privium Fund Management UK Ltd24,554$53K0.0%-51.3%0.062% 5/1/2023Virtu Financial LLC13,722$30K0.0%N/A0.035% 5/1/2023 Marquette Asset Management LLC55,757$123K0.0%-18.4%0.140% 4/27/2023 RiverVest Venture Management LLC2,936,281$6.49M7.5%+36.7%7.387% 2/13/2023 BML Capital Management LLC221,830$243K0.2%N/A0.942% 2/9/2023 Privium Fund Management UK Ltd50,400$55K0.0%N/A0.214% 1/12/2023 Marquette Asset Management LLC68,357$75K0.0%+6.7%0.290% 11/14/2022Ergoteles LLC23,032$32K0.0%-45.0%0.098% 11/10/2022Abingworth LLP1,792,518$2.47M0.8%N/A7.608% 10/18/2022 Bailard Inc.21,166$29K0.0%N/A0.090% 7/15/2022 Marquette Asset Management LLC64,090$112K0.0%+56.9%0.273% 2/10/2022 Acadian Asset Management LLC71,756$318K0.0%N/A0.306% 1/19/2022 Marquette Asset Management LLC40,853$182K0.0%N/A0.174% 11/16/2021 Laurion Capital Management LP11,337$68K0.0%-24.2%0.048% 11/15/2021 Deerfield Management Company L.P. Series C2,200,000$13.22M0.3%+7.5%9.411% 11/15/2021 Rock Springs Capital Management LP1,617,601$9.72M0.2%+0.8%6.919% 11/15/2021 Caas Capital Management LP27,546$166K0.0%-70.2%0.118% 11/12/2021 Trexquant Investment LP11,998$72K0.0%N/A0.051% 11/10/2021Granite Point Capital Management L.P.63,614$382K0.0%-36.4%0.272% 11/8/2021 State Board of Administration of Florida Retirement System17,440$105K0.0%N/A0.075% 11/4/2021 Sands Capital Ventures LLC787,007$4.73M0.7%N/A3.366% 8/17/2021 Caas Capital Management LP92,412$1.04M0.0%N/A0.395% 8/16/2021California State Teachers Retirement System12,006$135K0.0%+14.0%0.051% 8/16/2021 Alyeska Investment Group L.P.19,413$218K0.0%N/A0.083% 8/16/2021 State Street Corp124,918$1.40M0.0%+31.8%0.534% 8/16/2021 Nuveen Asset Management LLC29,616$332K0.0%+159.3%0.127% 8/16/2021 Goldman Sachs Group Inc.10,770$121K0.0%-13.5%0.046% Bill Clinton Backing Biden Replacement??? (Ad)Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast.8/13/2021 Northern Trust Corp77,864$873K0.0%+2.3%0.334% 8/13/2021 Laurion Capital Management LP14,957$168K0.0%-25.2%0.064% 8/13/2021 Geode Capital Management LLC128,546$1.44M0.0%+17.3%0.551% 8/13/2021 Vanguard Group Inc.369,520$4.14M0.0%+96.0%1.584% 8/13/2021 FMR LLC1,185,673$13.29M0.0%-0.8%5.082% 8/12/2021 JPMorgan Chase & Co.163,857$1.84M0.0%-9.0%0.702% 8/11/2021 Bank of New York Mellon Corp25,566$286K0.0%+33.3%0.110% 8/11/2021 BlackRock Inc.419,789$4.71M0.0%+21.6%1.799% 5/18/2021 Millennium Management LLC73,081$1.21M0.0%-41.4%0.313% 5/18/2021 PFM Health Sciences LP489,631$8.13M0.2%-7.5%2.099% 5/18/2021 Citadel Advisors LLC1,702,805$28.27M0.0%+0.1%7.299% 5/17/2021 Rock Springs Capital Management LP1,579,301$26.22M0.6%-3.2%6.769% 5/17/2021 Nuveen Asset Management LLC11,422$190K0.0%-49.6%0.049% 5/17/2021 Goldman Sachs Group Inc.12,447$207K0.0%N/A0.053% 5/14/2021 Credit Suisse AG23,899$397K0.0%-7.1%0.103% 5/13/2021 Bank of New York Mellon Corp19,180$318K0.0%+42.2%0.082% 5/12/2021 Northern Trust Corp76,144$1.26M0.0%-3.9%0.327% 5/12/2021 Geode Capital Management LLC109,547$1.82M0.0%-6.8%0.470% 5/12/2021 JPMorgan Chase & Co.180,023$2.99M0.0%-4.7%0.773% 5/11/2021 New York State Common Retirement Fund6,000$100K0.0%+87.5%0.026% 5/7/2021 BlackRock Inc.345,306$5.73M0.0%+4.0%1.482% 4/23/2021 Strs Ohio2,400$39K0.0%+41.2%0.010% 2/19/2021 PFM Health Sciences LP529,311$12.87M0.5%N/A2.280% 2/19/2021 JPMorgan Chase & Co.188,827$4.59M0.0%N/A0.813% 2/17/2021 Sands Capital Management LLC787,007$19.13M0.0%N/A3.390% 2/16/2021 Nuveen Asset Management LLC22,666$551K0.0%N/A0.098% 2/16/2021 Charles Schwab Investment Management Inc.40,352$981K0.0%N/A0.174% 2/13/2021 American International Group Inc.4,050$98K0.0%N/A0.017% 2/12/2021 Caas Capital Management LP10,000$243K0.0%N/A0.043% 2/12/2021 Laurion Capital Management LP20,000$486K0.0%N/A0.086% 2/12/2021AWM Investment Company Inc.40,000$972K0.1%N/A0.172% 2/12/2021 Credit Suisse AG25,713$625K0.0%N/A0.111% 2/11/2021 Northern Trust Corp79,204$1.93M0.0%N/A0.341% 2/11/2021 Citigroup Inc.1,282$31K0.0%N/A0.006% 2/9/2021 Wells Fargo & Company MN3,724$90K0.0%N/A0.016% 2/9/2021 Bank of New York Mellon Corp13,492$328K0.0%N/A0.058% 2/8/2021 New York State Common Retirement Fund3,200$78K0.0%N/A0.014% 2/6/2021Granite Point Capital Management L.P.100,000$2.43M0.1%N/A0.431% 2/5/2021 BlackRock Inc.332,032$8.07M0.0%N/A1.430% 2/4/2021 Aisling Capital Management LP1,205,511$29.31M5.0%N/A5.193% (Data available from 1/1/2016 forward) SPRB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SPRB shares? During the previous two years, 17 institutional investors and hedge funds held shares of Spruce Biosciences. The most heavily invested institutionals were Armistice Capital LLC ($6.53M), RiverVest Venture Management LLC ($6.49M), Carlyle Group Inc. ($6.40M), AIGH Capital Management LLC ($6.22M), Abingworth LLP ($2.47M), Worth Venture Partners LLC ($1.54M), and Rosalind Advisors Inc. ($1.19M).Learn more on SPRB's institutional investors. What percentage of Spruce Biosciences stock is owned by institutional investors? 91.71% of Spruce Biosciences stock is owned by institutional investors. Learn more on SPRB's institutional investor holdings. Which institutional investors have been buying Spruce Biosciences stock? Of the 14 institutional investors that purchased Spruce Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Carlyle Group Inc. ($2.90M), AIGH Capital Management LLC ($2.12M), Abingworth LLP ($1.79M), RiverVest Venture Management LLC ($788K), Acadian Asset Management LLC ($368.83K), Worth Venture Partners LLC ($249.31K), and BML Capital Management LLC ($221.83K). How much institutional buying is happening at Spruce Biosciences? Institutional investors have bought a total of 8,890,029 shares in the last 24 months. This purchase volume represents approximately $17.90M in transactions. Which Spruce Biosciences major shareholders have been selling company stock? The following institutional investors have sold Spruce Biosciences stock in the last 24 months: Armistice Capital LLC ($1.27M), Rosalind Advisors Inc. ($77.97K), Privium Fund Management UK Ltd ($25.85K), Ergoteles LLC ($18.87K), and Marquette Asset Management LLC ($12.60K). How much institutional selling is happening at Spruce Biosciences? Institutional investors have sold a total of 1,403,287 shares in the last 24 months. This volume of shares sold represents approximately $3.59M in transactions. Related Companies: Fortress Biotech Institutional Ownership BriaCell Therapeutics Institutional Ownership NRx Pharmaceuticals Institutional Ownership Acurx Pharmaceuticals Institutional Ownership Apollomics Institutional Ownership Daré Bioscience Institutional Ownership ImmunoPrecise Antibodies Institutional Ownership Viracta Therapeutics Institutional Ownership Marker Therapeutics Institutional Ownership ProMIS Neurosciences Institutional Ownership This page (NASDAQ:SPRB) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThe Next Industry Being Reshaped By AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceUrgent Nvidia WarningAltimetryMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spruce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.